Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT06291987
Title Ivosidenib and Ruxolitinib in Patients With Advanced Blood Cancers That Have IDH1 Gene MutationPhase MPNs (MPN)
Acronym MPN
Recruitment Not yet recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors University of Chicago
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Additional content available in CKB BOOST